UAB "Apeironpharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 502,073 |
| 129,068 |
| 51,886 |
| 44,103 |
| 11,338 |
| 37.09 |
| 8.78 |
| 128,557 |
| 71,475 |
| 89,293 |
| 110,739 |
| 2023 |
|---|
| 537,218 |
| 134,305 |
| 78,849 |
| 67,022 |
| 16,756 |
| 36.50 |
| 12.48 |
| 214,399 |
| 366,388 |
| 444,776 |
| 151,159 |
| 2024 |
|---|
| 501,278 |
| 125,320 |
| 74,743 |
| 63,532 |
| 15,883 |
| 37.44 |
| 12.67 |
| 277,931 |
| 305,251 |
| 533,777 |
| 84,694 |
Register and
explore Okredo data| 2024 |
|---|
| 501,278 |
| 125,320 |
| 74,743 |
| 63,532 |
| 15,883 |
| 37.44 |
| 12.67 |
| 277,931 |
| 305,251 |
| 533,777 |
| 84,694 |
Register and
explore Okredo dataTurnover (€)
2024
Turnover (€)
501,278 €-7 % *
Sales per employee (€)
125,320 €-7 % *
Profit before tax (€)
74,743 €-5 % *
Net Profit (€)
63,532 €-5 % *
Profit per employee (€)
15,883 €-5 % *
Total profitability (%)
37.44 %2.58 % *
Net profitability (%)
12.67 %1.52 % *
Equity (€)
277,931 €30 % *
Amounts Payable And Liabilities (€)
305,251 €-17 % *
Non-current Assets (€)
533,777 €20 % *
CurrentAssets (€)
84,694 €-44 % *
